日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinicopathological Status and Prognostic Factors of Recurrent Epithelial Ovarian Cancer in Japan: Retrospective Survey of JSOG Committee on Gynecologic Oncology

日本复发性上皮性卵巢癌的临床病理特征和预后因素:日本妇产科协会妇科肿瘤委员会的回顾性调查

Watanabe, Yoh; Baba, Tsukasa; Soeda, Shu; Tokunaga, Hideki; Yamagami, Wataru; Nomura, Hiroyuki; Kobayashi, Yoichi; Kawana, Kei; Yoshino, Kiyoshi; Yokoyama, Yoshihito; Nishi, Hirotaka; Kobayashi, Hiroaki; Matsuzawa, Yukiko; Oyamada, Shunsuke; Takahashi, Satoru; Nagase, Satoru

Proton beam therapy as an effective treatment option for recurrent endometrial cancer

质子束疗法是治疗复发性子宫内膜癌的有效方法

Endo, Yuta; Takagawa, Yoshiaki; Yoshimoto, Yuki; Ando, Koki; Nishikawa, Rei; Machida, Masanori; Dai, Yuntao; Seto, Ichiro; Suzuki, Motohisa; Kato, Takahiro; Furukawa, Shigenori; Soeda, Shu; Fujimori, Keiya; Murakami, Masao

Proton beam therapy achieves excellent local control for recurrent epithelial ovarian cancer: a single-center retrospective study

质子束疗法对复发性上皮性卵巢癌具有极佳的局部控制效果:一项单中心回顾性研究

Endo, Yuta; Takagawa, Yoshiaki; Yoshimoto, Yuki; Machida, Masanori; Dai, Yuntao; Azami, Yusuke; Seto, Ichiro; Takayama, Kanako; Suzuki, Motohisa; Nakasato, Tatsuhiko; Kikuchi, Yasuhiro; Kato, Takahiro; Yamaguchi, Akiko; Soeda, Shu; Fujimori, Keiya; Murakami, Masao

Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)

比较一线化疗联合或不联合贝伐单抗治疗晚期卵巢透明细胞癌的疗效(东北妇科肿瘤中心:TGCU-RS001A 研究)

Shoji, Tadahiro; Takatori, Eriko; Nagasawa, Takayuki; Kagabu, Masahiro; Baba, Tsukasa; Shigeto, Tatsuhiko; Matsumura, Yukiko; Shimizu, Dai; Terada, Yukihiro; Seino, Manabu; Ohta, Tsuyoshi; Nagase, Satoru; Shigeta, Shogo; Tokunaga, Hideki; Shimada, Muneaki; Kaiho-Sakuma, Michiko; Furukawa, Shigenori; Soeda, Shu; Watanabe, Takafumi; Takahashi, Fumiaki; Yokoyama, Yoshihito

Effectiveness of the Traditional Japanese Medicine Goshajinkigan in Preventing Paclitaxel-Induced Peripheral Neuropathy: A Multicenter Randomized Comparative Trial

日本传统药物五车神气丸预防紫杉醇诱导周围神经病变的有效性:一项多中心随机对照试验

Matsumura, Yukiko; Futagami, Masayuki; Baba, Tsukasa; Soeda, Shu; Watari, Hidemichi; Terada, Yukihiro; Tokunaga, Hideki; Nagase, Satoru; Nakanishi, Toru; Kaiho, Michiko; Yokoyama, Yoshihito

Association between specific human leukocyte antigen alleles and development of thyroid immune-related adverse event

特定人类白细胞抗原等位基因与甲状腺免疫相关不良事件发生之间的关联

Sasaki, Eisaku; Natori, Yutaka; Tokuda, Emi; Kimura-Tsuchiya, Reiko; Suga, Junko; Kanazawa, Kenya; Koguchi, Tomoyuki; Kikuchi, Nobuyuki; Okabe, Naoyuki; Murono, Shigeyuki; Tachibana, Kazunoshin; Soeda, Shu; Shimabukuro, Michio; Saji, Shigehira

Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction: A Case Report

细胞减灭术后,尼拉帕利成功控制奥拉帕尼治疗进展的卵巢癌:病例报告

Endo, Yuta; Kamo, Norihito; Kato, Asami; Sato, Tetsu; Okabe, Chikako; Furukawa, Shigenori; Watanabe, Takafumi; Soeda, Shu

Diaphragmatic clear cell carcinoma with Lynch syndrome after surgery for atypical endometrial hyperplasia and ovarian endometriosis: A case report

膈肌透明细胞癌合并林奇综合征,曾行非典型子宫内膜增生和卵巢子宫内膜异位症手术:病例报告

Ueda, Makiko; Watanabe, Takafumi; Momma, Tomoyuki; Kanke, Yasuyuki; Kato, Asami; Okabe, Chikako; Sato, Tetsu; Kamo, Norihito; Endo, Yuta; Furukawa, Shigenori; Soeda, Shu; Fujimori, Keiya

Differentiation of ovarian serous carcinoma from ovarian clear cell carcinoma using a 10-gene signature selected by comprehensive gene expression analysis

利用综合基因表达分析筛选出的10基因特征鉴别卵巢浆液性癌和卵巢透明细胞癌

Nomura, Shinji; Watanabe, Takafumi; Honma, Reiko; Matsukura, Susumu; Ito, Emi; Imai, Jun-Ichi; Kiko, Yuichiro; Suzuki, Osamu; Hashimoto, Yuko; Kojima, Manabu; Furukawa, Shigenori; Soeda, Shu; Watanabe, Shinya; Fujimori, Keiya

Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy

新辅助化疗后行全盆腔脏器切除术成功治疗局部晚期宫颈癌

Endo, Yuta; Soeda, Shu; Yoshimoto, Yuki; Todate, Yukitoshi; Hashimoto, Tatsuru; Furukawa, Shigenori; Teranishi, Yasushi; Fujimori, Keiya